30J Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - IDEAYA Biosciences Inc

Watchlist Manager

Watchlist

Price: 31.98 EUR -0.81%

Market Cap: €2.7B

	IDEAYA Biosciences Inc F:30J	US
A	AGFA Gevaert NV XMUN:AGE	BE
B	Blackbaud Inc F:BNK	US
S	Shenzhen Investment Ltd F:SHS	HK
	Energia Innovacion y Desarrollo Fotovoltaico SA F:F63	ES

Profitability Summary

IDEAYA Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-93%

Negative 3Y Average Operating Margin

-2.236%

Operating Margin is Increasing

-507% > -93%

Negative Net Margin

-75%

Negative 3Y Average Net Margin

-1.860%

Net Margin is Increasing

-440% > -75%

Negative Free Cash Flow Margin

-49%

Negative 3Y Average Free Cash Flow Margin

-1.658%

Free Cash Flow Margin is Increasing

-496% > -49%

Negative ROE

-16%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-100%

ROIC is Increasing

-298% > -47%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.